Cambrios Technologies makes initial close at $2.6m of planned investment round.
Cambrios Technologies, a US-based company developing electronic materials for the display industry formerly known as Semzyme, has raised $2.6m as the first step on an expected $15m round.
The stock is preferred to the $14.5m series D round closed in November last year, according to the company’s regulatory filing first seen by CB Insights.
The investors in the D round were venture capital firms Arch Venture Partners, Alloy Ventures, Oxford Bioscience Partners, Altitude Life Science Ventures, Avalon Ventures,…
